Jelinek Richard M 4
4 · Evolent Health, Inc. · Filed Mar 10, 2025
Insider Transaction Report
Form 4
Jelinek Richard M
Director
Transactions
- Purchase
Class A Common Stock
2025-03-07$9.16/sh+15,000$137,400→ 15,000 total(indirect: By Trust) - Purchase
Class A Common Stock
2025-03-07$9.09/sh+15,000$136,350→ 15,000 total(indirect: By the Richard M Jelinek GST)
Holdings
- 14,458
Class A Common Stock
Footnotes (1)
- [F1]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.